Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli

scientific article published on November 1996

Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID174445
P698PubMed publication ID8890239

P2093author name stringY Abe
A M Dannenberg
B H Schofield
J E Estep
K Sugisaki
M L Pitt
P J Converse
P2860cites workThe critical-orifice liquid impinger as a sampler for bacterial aerosolsQ30500230
Macrophage Function in Infectious Disease with Inbred Rabbits.Q35548095
Macrophage functional heterogeneity in vivo. Macrolocal and microlocal macrophage activation, identified by double-staining tissue sections of BCG granulomas for pairs of enzymesQ35863125
The role of cathepsin D in the pathogenesis of tuberculosis. A histochemical study employing unlabeled antibodies and the peroxidase-antiperoxidase complexQ35875109
Histochemical studies relating the activation of macrophages to the intracellular destruction of tubercle bacilliQ36077086
The in vitro differentiation of mononuclear phagocytes. 3. The reversibility of granule and hydrolytic enzyme formation and the turnover of granule constituentsQ36267740
Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosisQ37066653
Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymesQ37197306
Participation of pulmonary alveolar epithelial cells in lung inflammationQ40460967
Immunopathogenesis of pulmonary tuberculosisQ40868525
Sterol balance and cholesterol absorption in inbred strains of rabbits hypo- or hyperresponsive to dietary cholesterolQ41892550
Liquefaction of caseous foci in tuberculosisQ43446242
Immunosuppression and alteration of resistance to pulmonary tuberculosis in guinea pigs by protein undernutritionQ44064295
Improved Techniques Using Giemsa Stained Glycol Methacrylate Tissue Sections to Quantitate Basophils and Other Leukocytes in Inflammatory Skin LesionsQ46455609
Enzymes in tuberculous lesions hydrolyzing protein, hyaluronic acid and chondroitin sulfate: a study of isolated macrophages and developing and healing rabbit BCG lesions with substrate film techniques; the shift of enzyme pH optima towards neutraliQ53903412
Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide.Q54063082
The local nature of immunity in tuberculosis, illustrated histochemically in dermal BCG lesions.Q54627914
Secretion of lipoprotein cholesterol by perfused livers from rabbits hypo- or hyperresponsive to dietary cholesterol: greater dietary cholesterol-induced secretion in hyperresponsive rabbitsQ68096460
Low-density lipoprotein turnover in inbred strains of rabbits hypo- or hyperresponsive to dietary cholesterolQ68206399
Prevention of tuberculous cavity formation by immunosuppressive drugsQ70093521
Improvement in the histochemical demonstration of acid phosphatase, beta-galactosidase and nonspecific esterase in glycol methacrylate tissue sections by cold temperature embeddingQ70460843
Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. 3. The turnover of macrophages and its relation to their activation and antimicrobial immunity in primary BCG lesions and those of reinfQ70496972
Lesions of acute inhaled lethal ricin intoxication in rhesus monkeysQ71347057
ON PHAGOCYTES: THEIR STRUCTURES AND PARTICIPATION IN INFLAMMATIONQ76925927
P433issue11
P407language of work or nameEnglishQ1860
P921main subjecttuberculosisQ12204
P304page(s)4776-4787
P577publication date1996-11-01
P1433published inInfection and ImmunityQ6029193
P1476titleCavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli
P478volume64

Reverse relations

cites work (P2860)
Q33837437A modified scoring system to describe gross pathology in the rabbit model of tuberculosis
Q37857711A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis
Q41835746Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology
Q35534267Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.
Q28364778Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences
Q41572870Assessment of the Efficacy of New Anti-Tuberculosis Drugs
Q35008119Association between tuberculin skin test result and clinical presentation of tuberculosis disease
Q36576348Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis
Q38274693Chemokines in tuberculosis: the good, the bad and the ugly
Q37692457Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.
Q36046773Different Strains ofMycobacterium tuberculosisCause Various Spectrums of Disease in the Rabbit Model of Tuberculosis
Q33944657Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research
Q34775404Evaluation of mycobacterial virulence using rabbit skin liquefaction model
Q41666687Genetic vaccination against tuberculosis.
Q39521285Homogeneity of antibody responses in tuberculosis patients
Q44178755Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection
Q37714067In vitro and in vivo studies of a rapid and selective breath test for tuberculosis based upon mycobacterial CO dehydrogenase.
Q33902234In vivo administration of mycobacterial cord factor (Trehalose 6, 6'-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits.
Q36171653Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography
Q39640376Infection of mice with aerosolized Mycobacterium tuberculosis: use of a nose-only apparatus for delivery of low doses of inocula and design of an ultrasafe facility
Q28477456Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment
Q21136107Mathematical Modeling of Tuberculosis Bacillary Counts and Cellular Populations in the Organs of Infected Mice
Q37120423Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.
Q54520033Mycobacteria-induced granuloma necrosis depends on IRF-1.
Q28385840Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation
Q36882480Mycobacterium tuberculosis exploits human interferon γ to stimulate macrophage extracellular trap formation and necrosis.
Q34213787Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence
Q37898308Pathology of post primary tuberculosis of the lung: an illustrated critical review
Q43668652Pathomorphogenesis of tubercular histologic changes: mechanisms of granuloma formation, maintenance and necrosis
Q40568831Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing
Q34189865Perspectives on Clinical and Preclinical Testing of New Tuberculosis Vaccines
Q37282737Progress and new directions in genetics of tuberculosis: an NHLBI working group report
Q33999646Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy.
Q62738057Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction
Q37099497Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.
Q36575821Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits
Q38882974The Small Breathing Amplitude at the Upper Lobes Favors the Attraction of Polymorphonuclear Neutrophils to Mycobacterium tuberculosis Lesions and Helps to Understand the Evolution toward Active Disease in An Individual-Based Model
Q37523145The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli
Q38193087The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies
Q89724634Tuberculosis vaccine development: from classic to clinical candidates
Q34480272Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.
Q36747136Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci
Q34001917Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method.

Search more.